https://www.invengene.com/resource/sugammadex-injectable-receives-multiple-regulatory-approvals/2026-03-02T12:07:42+05:30https://www.invengene.com/resource/sugammadex-injectable-receives-multiple-regulatory-approvals-2/2026-03-02T12:09:55+05:30https://www.invengene.com/resource/sugammadex-injectable-receives-multiple-regulatory-approvals-5/2026-03-02T12:05:26+05:30https://www.invengene.com/resource/avon-health-junction/2026-07-13T11:07:48+05:30https://www.invengene.com/resource/invengene-wins-pharma-startup-of-the-year-at-fe-pharma-awards-summit-2026/2026-07-13T11:11:03+05:30https://www.invengene.com/resource/invengene-expands-africa-footprint-with-parecoxib-injection-approval-in-zimbabwe/2026-03-31T18:34:16+05:30https://www.invengene.com/resource/double-honour-for-invengene-at-assocham-2nd-pharma-summit-excellence-awards-2026/2026-07-10T18:36:08+05:30https://www.invengene.com/resource/there-should-be-a-stronger-framework-for-ip-creation-and-protection-in-the-pharmaceutical-context/2026-07-14T13:01:29+05:30https://www.invengene.com/resource/from-cost-to-capability-how-invengene-is-rewriting-indias-injectables-playbook/2026-07-14T13:00:31+05:30https://www.invengene.com/resource/indian-pharma-sees-next-growth-phase-to-be-driven-by-formulation-science/2026-07-14T13:00:47+05:30https://www.invengene.com/resource/beyond-scale-rethinking-new-frontiers-in-building-excellence/2026-07-14T12:59:42+05:30https://www.invengene.com/resource/invengene-a-purpose-led-approach-to-advancing-pharmaceutical-formulations/2026-07-14T13:01:08+05:30